Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 115 Squamous Cell Carcinoma of Head and Neck 61 Triple Negative Breast Neoplasms 57 Melanoma 54 Neoplasm Metastasis 49 Lung Neoplasms 49 Breast Neoplasms 41 Neoplasms 36 Colorectal Neoplasms 35 Head and Neck Neoplasms 25 Endometrial Neoplasms 25 Carcinoma, Renal Cell 24 Uterine Cervical Neoplasms 21 Stomach Neoplasms 21 Ovarian Neoplasms 21 Carcinoma, Transitional Cell 21 Urinary Bladder Neoplasms 20 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Esophageal Neoplasms 16 Recurrence 15 Carcinoma, Hepatocellular 14 Pancreatic Neoplasms 13 Sarcoma 12 Carcinoma, Squamous Cell 12 Glioblastoma 11 Esophageal Squamous Cell Carcinoma 11 Carcinoma 11 Prostatic Neoplasms 10 Brain Neoplasms 10 Carcinoma, Merkel Cell 9

Interventions

Exercise 36 Nutritional Status 5 Control Groups 4 Resistance Training 3 High-Intensity Interval Training 3 lime 2 Vitamin D 2 Standard of Care 2 Preoperative Exercise 2 Dosage Forms 2 Diet 2 tislelizumab 1 pembrolizumab 1 oncomodulin 1 diacetamate 1 blueberry extract 1 beta-Glucans 1 Whey Proteins 1 Wearable Electronic Devices 1 Walking 1 Transcranial Direct Current Stimulation 1 Tea 1 Tablets 1 TEMPO 1 Spermine Synthase 1 Roflumilast 1 Rehabilitation 1 Radiotherapy 1 Probiotics 1 Physical Therapy Modalities 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motor Activity × pembrolizumab × Clear all

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡